Cargando…
Predictors for INR-control in a well-managed warfarin treatment setting
Warfarin is well studied in patients with non-valvular atrial fibrillation (AF). It has low complication rates for patients achieving individual Time in Therapeutic Range (iTTR) > 70%. The risk scores SAMe-TT(2)R(2) and PROSPER are designed to predict future TTR, but are derived from a heterogene...
Autores principales: | Björck, Fredrik, Kadhim, Hayder, Själander, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394450/ https://www.ncbi.nlm.nih.gov/pubmed/30411185 http://dx.doi.org/10.1007/s11239-018-1765-4 |
Ejemplares similares
-
Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
por: Eljilany, Islam, et al.
Publicado: (2021) -
A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR
por: Ur Rahman, Saad
Publicado: (2023) -
Warfarin/herbal drink interaction: Elevated INR: case report
Publicado: (2021) -
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
por: Jansson, M., et al.
Publicado: (2023) -
How Well Does the Target INR Level Maintain in Warfarin-Treated Patients with Non-ValvularAtrial Fibrillation?
por: Kim, Jun Hyung, et al.
Publicado: (2009)